Ardian launches sale of German pharma firm Riemser -sources
March 14, 2018 at 14:18 PM EDT
FRANKFURT, March 14 (Reuters) - Buyout group Ardian has launched the sale of German healthcare firm Riemser Pharma, which may fetch a valuation of more than 400 million euros ($495 million), people close to the matter said.
